oxymatrine has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Liu, L; Wang, J; Xiong, Y; Zhu, H | 1 |
| Hu, Z; Li, Y; Wang, S; Xiao, Z; Zhang, J; Zhang, Y | 1 |
2 other study(ies) available for oxymatrine and Adenocarcinoma
| Article | Year |
|---|---|
Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Alkaloids; Antigens, CD; Antiviral Agents; Apoptosis; Biomarkers, Tumor; Cadherins; Case-Control Studies; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prognosis; Quinolizines; RNA, Long Noncoding; Survival Rate; Tumor Cells, Cultured | 2018 |
Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice.
Topics: Adenocarcinoma; Alkaloids; Animals; Cachexia; Cell Line; Colonic Neoplasms; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Matrines; Mice; Mice, Inbred BALB C; Quinolizines; Tumor Necrosis Factor-alpha | 2008 |